Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varda Rotter

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Oncogene|July 26, 2002
DNA binding and 3'-5' exonuclease activity in the murine alternatively-spliced p53 proteinZippora Shakked, Michael Yavnilovitch, A Joseph Kalb Gilboa, et al.
European Journal of Immunology|October 21, 2004
Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: anti-idiotypes to the anti-p53 antibody are anti-DNAJohannes Herkel, Na'aman Kam, Neta Erez, et al.
Autoimmunity|May 27, 2003
Prevalence of autoantibodies to the p53 protein in autoimmune hepatitisJohannes Herkel, Jan-Philip Modrow, Sonja Bamberger, et al.
Plos One|August 30, 2007
Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start siteYuval Tabach, Ran Brosh, Yossi Buganim, et al.
Carcinogenesis|October 14, 2003
The role of p53 in base excision repair following genotoxic stressIrit Zurer, Lorne J Hofseth, Yehudit Cohen, et al.
BMC Genomics|November 27, 2010
Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cellsXi-Song Ke, Yi Qu, Yang Cheng, et al.
Cancer Research|August 30, 2018
A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem CellsGabriela Koifman, Yoav Shetzer, Shay Eizenberger, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancyGianluca Bossi, Francesco Marampon, Revital Maor-Aloni, et al.
Biochemistry|January 3, 2019
The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 MotifYoel A Klug, Roland Schwarzer, Etai Rotem, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2017
Diverse p53/DNA binding modes expand the repertoire of p53 response elementsPratik Vyas, Itai Beno, Zhiqun Xi, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Oncogene|July 26, 2002
DNA binding and 3'-5' exonuclease activity in the murine alternatively-spliced p53 proteinZippora Shakked, Michael Yavnilovitch, A Joseph Kalb Gilboa, et al.
European Journal of Immunology|October 21, 2004
Monoclonal antibody to a DNA-binding domain of p53 mimics charge structure of DNA: anti-idiotypes to the anti-p53 antibody are anti-DNAJohannes Herkel, Na'aman Kam, Neta Erez, et al.
Autoimmunity|May 27, 2003
Prevalence of autoantibodies to the p53 protein in autoimmune hepatitisJohannes Herkel, Jan-Philip Modrow, Sonja Bamberger, et al.
Plos One|August 30, 2007
Wide-scale analysis of human functional transcription factor binding reveals a strong bias towards the transcription start siteYuval Tabach, Ran Brosh, Yossi Buganim, et al.
Carcinogenesis|October 14, 2003
The role of p53 in base excision repair following genotoxic stressIrit Zurer, Lorne J Hofseth, Yehudit Cohen, et al.
BMC Genomics|November 27, 2010
Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cellsXi-Song Ke, Yi Qu, Yang Cheng, et al.
Cancer Research|August 30, 2018
A Mutant p53-Dependent Embryonic Stem Cell Gene Signature Is Associated with Augmented Tumorigenesis of Stem CellsGabriela Koifman, Yoav Shetzer, Shay Eizenberger, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancyGianluca Bossi, Francesco Marampon, Revital Maor-Aloni, et al.
Biochemistry|January 3, 2019
The HIV gp41 Fusion Protein Inhibits T-Cell Activation through the Lentiviral Lytic Peptide 2 MotifYoel A Klug, Roland Schwarzer, Etai Rotem, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2017
Diverse p53/DNA binding modes expand the repertoire of p53 response elementsPratik Vyas, Itai Beno, Zhiqun Xi, et al.
Pageof 13